IT1229531B - DIDEOXIDE / HYDROCARBOCYCLIC NUCLEOSID COMPOUNDS AND PHARMACEUTICAL FORMULATION CONTAINING THEM - Google Patents

DIDEOXIDE / HYDROCARBOCYCLIC NUCLEOSID COMPOUNDS AND PHARMACEUTICAL FORMULATION CONTAINING THEM

Info

Publication number
IT1229531B
IT1229531B IT8947546A IT4754689A IT1229531B IT 1229531 B IT1229531 B IT 1229531B IT 8947546 A IT8947546 A IT 8947546A IT 4754689 A IT4754689 A IT 4754689A IT 1229531 B IT1229531 B IT 1229531B
Authority
IT
Italy
Prior art keywords
dideoxide
hydrocarbocyclic
nucleosid
compounds
pharmaceutical formulation
Prior art date
Application number
IT8947546A
Other languages
Italian (it)
Other versions
IT8947546A0 (en
Inventor
Vince Robert
Hua Mei
Leslie Myers Peter
Storer Richard
Original Assignee
Univ Minnesota
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/146,252 external-priority patent/US4916224A/en
Priority claimed from GB888821011A external-priority patent/GB8821011D0/en
Priority claimed from US07/278,652 external-priority patent/US4931559A/en
Application filed by Univ Minnesota filed Critical Univ Minnesota
Publication of IT8947546A0 publication Critical patent/IT8947546A0/en
Application granted granted Critical
Publication of IT1229531B publication Critical patent/IT1229531B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IT8947546A 1988-01-20 1989-01-19 DIDEOXIDE / HYDROCARBOCYCLIC NUCLEOSID COMPOUNDS AND PHARMACEUTICAL FORMULATION CONTAINING THEM IT1229531B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/146,252 US4916224A (en) 1988-01-20 1988-01-20 Dideoxycarbocyclic nucleosides
GB888821011A GB8821011D0 (en) 1988-09-07 1988-09-07 Chemical compounds
US07/278,652 US4931559A (en) 1988-01-20 1988-12-05 Optically-active isomers of dideoxycarbocyclic nucleosides

Publications (2)

Publication Number Publication Date
IT8947546A0 IT8947546A0 (en) 1989-01-19
IT1229531B true IT1229531B (en) 1991-09-04

Family

ID=27264063

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8947546A IT1229531B (en) 1988-01-20 1989-01-19 DIDEOXIDE / HYDROCARBOCYCLIC NUCLEOSID COMPOUNDS AND PHARMACEUTICAL FORMULATION CONTAINING THEM

Country Status (29)

Country Link
JP (1) JP2793825B2 (en)
KR (1) KR0127137B1 (en)
AT (1) AT397801B (en)
AU (2) AU626278B2 (en)
BE (1) BE1003815A4 (en)
CA (1) CA1339896C (en)
CH (1) CH679152A5 (en)
DE (1) DE3901502C2 (en)
DK (1) DK175131B1 (en)
ES (1) ES2010091A6 (en)
FI (1) FI93546C (en)
FR (1) FR2626002B1 (en)
GB (1) GB2217320B (en)
GR (1) GR890100033A (en)
HU (1) HU203755B (en)
IE (1) IE62275B1 (en)
IL (1) IL88999A (en)
IT (1) IT1229531B (en)
LU (1) LU87437A1 (en)
MY (1) MY103801A (en)
NL (1) NL8900122A (en)
NO (1) NO169123C (en)
NZ (1) NZ227663A (en)
OA (1) OA09031A (en)
PL (1) PL163814B1 (en)
PT (1) PT89482B (en)
RU (1) RU2114846C1 (en)
SE (1) SE505213C2 (en)
YU (1) YU47791B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1215339B (en) * 1987-01-14 1990-02-08 Co Pharma Corp Srl PROCEDURE FOR THE PREPARATION OF 9- (HYDROXIALCHIL) -IPOXANTINE
US5631370A (en) 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US4939252A (en) * 1989-04-20 1990-07-03 Hoffmann-La Roche Inc. Novel intermediates for the preparation of Carbovir
ES2136061T3 (en) * 1989-06-27 1999-11-16 Wellcome Found THERAPEUTIC NUCLEOSIDES.
GB8916479D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916480D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916477D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
GB8916478D0 (en) * 1989-07-19 1989-09-06 Glaxo Group Ltd Chemical process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
US5126452A (en) * 1990-04-06 1992-06-30 Glaxo Inc. Synthesis of purine substituted cyclopentene derivatives
US5144034A (en) * 1990-04-06 1992-09-01 Glaxo Inc. Process for the synthesis of cyclopentene derivatives of purines
US5057630A (en) * 1990-04-06 1991-10-15 Glaxo Inc. Synthesis of cyclopentene derivatives
US5241069A (en) * 1990-04-06 1993-08-31 Glaxo Inc. Carbonate intermediates for the synthesis of purine substituted cyclopentene derivatives
GB9108376D0 (en) * 1991-04-19 1991-06-05 Enzymatix Ltd Cyclopentenes
HUT74989A (en) * 1993-11-12 1997-03-28 Merrell Pharma Inc 6-oxo-nucleosides useful as immunosuppressants
GB9721780D0 (en) * 1997-10-14 1997-12-10 Glaxo Group Ltd Process for the synthesis of chloropurine intermediates
DE59905679D1 (en) 1998-10-30 2003-06-26 Lonza Ag METHOD FOR PRODUCING 4 - [(2 ', 5'-DIAMINO-6'-HALOGENPYRIMIDIN-4'-YL) AMINO] -CYCLOPENT-2-ENYLMETHANOLS
DK1124805T3 (en) * 1998-10-30 2003-09-15 Lonza Ag Process for Preparation of 4 - [(2 ', 5'-Diamino-6'-halo-pyrimidin-4'-yl) amino] cyclopent-2-enylmethanols
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB9903091D0 (en) * 1999-02-12 1999-03-31 Glaxo Group Ltd Therapeutic nucleoside compound
AR039540A1 (en) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd MICROBICIDE COMPOUNDS WITH PIRIMIDINE OR TRIAZINE CONTENT
EP3831388B1 (en) 2018-07-27 2024-02-28 FUJIFILM Corporation Cyclopentenyl purine derivative or salt thereof for use in suppressing adenovirus
EP4125840A1 (en) 2020-03-27 2023-02-08 Som Innovation Biotech, S.A. Compounds for use in the treatment of synucleinopathies

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268672A (en) * 1977-02-09 1981-05-19 The Regents Of The University Of Minnesota Adenosine deaminase resistant antiviral purine nucleosides and method of preparation
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
JPS62177234A (en) * 1986-01-30 1987-08-04 Mitsubishi Heavy Ind Ltd Production device of carbon fiber by centrifugal spinning
IN164556B (en) * 1986-03-06 1989-04-08 Takeda Chemical Industries Ltd
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.

Also Published As

Publication number Publication date
IE62275B1 (en) 1995-01-25
IE890153L (en) 1989-07-20
NO890253D0 (en) 1989-01-19
NO169123C (en) 1992-05-13
FI890286A0 (en) 1989-01-19
DE3901502A1 (en) 1989-07-27
SE505213C2 (en) 1997-07-14
FI93546C (en) 1995-04-25
NO169123B (en) 1992-02-03
ATA10689A (en) 1993-11-15
GB8901187D0 (en) 1989-03-15
CA1339896C (en) 1998-06-02
PT89482A (en) 1989-10-04
SE8900192L (en) 1989-07-21
IL88999A0 (en) 1989-08-15
PL277261A1 (en) 1989-09-18
YU47791B (en) 1996-01-09
PT89482B (en) 1994-02-28
RU2114846C1 (en) 1998-07-10
KR0127137B1 (en) 1997-12-29
IT8947546A0 (en) 1989-01-19
CH679152A5 (en) 1991-12-31
IL88999A (en) 1994-12-29
GB2217320B (en) 1992-04-08
YU12389A (en) 1991-10-31
AU626278B2 (en) 1992-07-30
DK23489D0 (en) 1989-01-19
NL8900122A (en) 1989-08-16
MY103801A (en) 1993-09-30
JPH02196788A (en) 1990-08-03
FI890286A (en) 1989-07-21
DE3901502C2 (en) 2002-06-13
FI93546B (en) 1995-01-13
HU203755B (en) 1991-09-30
GR890100033A (en) 1994-03-31
NZ227663A (en) 1990-09-26
SE8900192D0 (en) 1989-01-19
KR890011902A (en) 1989-08-23
AU1018092A (en) 1992-03-12
FR2626002A1 (en) 1989-07-21
NO890253L (en) 1989-07-21
PL163814B1 (en) 1994-05-31
ES2010091A6 (en) 1989-10-16
AT397801B (en) 1994-07-25
AU2867189A (en) 1989-07-20
OA09031A (en) 1991-03-31
AU637015B2 (en) 1993-05-13
FR2626002B1 (en) 1994-01-28
DK23489A (en) 1989-07-21
JP2793825B2 (en) 1998-09-03
LU87437A1 (en) 1989-08-30
DK175131B1 (en) 2004-06-14
BE1003815A4 (en) 1992-06-23
HUT48887A (en) 1989-07-28
GB2217320A (en) 1989-10-25

Similar Documents

Publication Publication Date Title
IT1229531B (en) DIDEOXIDE / HYDROCARBOCYCLIC NUCLEOSID COMPOUNDS AND PHARMACEUTICAL FORMULATION CONTAINING THEM
DE10199066I1 (en) Pharmaceutical composition
DE3486441D1 (en) 3-hydroxypyrid-4-one and pharmaceutical compositions
LV10573A (en) Attenuation for pharmaceutical formulation
DK481989D0 (en) PHARMACEUTICAL FORMULATIONS
DE122004000023I2 (en) Pharmaceutical composition
DK229489D0 (en) PHARMACEUTICAL ORBATS
SE8801813L (en) PHARMACEUTICAL COMPOSITION
KR890701101A (en) Pharmaceutical composition
DK619987A (en) GALENIC FORMULATION
KR880701541A (en) Pharmaceutical formulation comprising microcapsules
DK489189A (en) PHARMACEUTICAL PREPARATION
IT8922216A0 (en) PHARMACEUTICAL SOLUTION
DK603988D0 (en) PHARMACEUTICAL PREPARATION
DK256290A (en) PHARMACEUTICAL PREPARATION CONTAINING DEOXYRIBONUCLEOSIDES FOR HEALING
MX5577A (en) PHARMACEUTICAL FORMULATION
DK336489D0 (en) PHARMACEUTICAL PREPARATION
DK142487D0 (en) PHARMACEUTICAL AGENTS
DK0511991T3 (en) Pharmaceutical formulation
ATA133288A (en) PHARMACEUTICAL COMPOSITION
IT1200467B (en) PHARMACEUTICAL FORMULATION
IT1224244B (en) ANOREXIZING PHARMACEUTICAL COMPOSITION INCLUDING 5-IDROSSITRPOFANO
ATA246089A (en) PHARMACEUTICAL COMPOSITION CONTAINING PHENYLCARBAMATE
PT85350A (en) XYLOMETAZOIN-CONTAINING PHARMACEUTICAL PREPARATIONS
LV5728A4 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19990128